Dr. Stephanie Nottrott

Dr. Stephanie Nottrott

Patent Attorney
European Patent Attorney

  • Sectors

    Biochemistry, Molecular Biology, Biotechnology
  • Languages

    German, English
  • Location


Stephanie Nottrott has profound expertise in handling global patent and trademark portfolios. Her clients include small and medium-sized biotech businesses and companies in the pharmaceutical industry as well as academia. Stephanie provides qualified advice in the area of patent and trademark law with particular focus on questions regarding national and international prosecution and the defence and enforcement of protective rights against third parties.

Stephanie has long-standing experience in successfully representing clients in opposition and appeal proceedings before the European Patent Office, the German Patent and Trade Mark Office and the European Union Intellectual Property Office. In patent litigation proceedings, she protects clients' interests before the German civil courts in collaboration with external lawyers. Her work includes freedom-to-operate analysis and validity opinions.

Before joining Isenbruck Bösl Hörschler in 2007, Stephanie gained insights into the field of intellectual property rights and US patent litigation while working as a scientific advisor for an international law firm in the US. With over 4 years of post-doctoral experience in the field of RNA/protein research, she has profound hands-on expertise in a variety of biochemical, cell and molecular biology methodologies, strong cross-cultural competence and authors several publications in highly ranked peer-reviewed scientific journals.

Stephanie Nottrott is admitted to practice before the German Patent and Trademark Office, the European Patent Office, the Federal Patent Court, the World Intellectual Property Organization and the European Union Intellectual Property Office.


  • European Patent Attorney
  • German Patent Attorney
  • European Trademark & Design Attorney
  • PhD in human biology (Degree of Dr. rer. physiol.), Phillips University of Marburg – Thesis in the field of protein/RNA biochemistry at the Max-Planck-Institute for Biophysical Chemistry, Göttingen
  • Degree of Diplom-Humanbiologin (Dipl. human. biol), IMT Institute of Molecular Biology and Tumor Research, Phillips University of Marburg


  • Institute of Professional Representatives before the European Patent Office
  • FICPI International Federation of Intellectual Property Attorneys
  • Chamber of Patent Attorneys (since 2016 member of the trade mark committee)
  • LES Licensing Executives Society
  • INTA International Trademark Association
  • Union-ip Union of European Practitioners in Intellectual Property
  • BIO Deutschland e. V. Member of the Committee Protection Rights and Technical Contracts


  • Icon
  • Icon
  • Icon
  • Icon
    Genetic Engineering
  • Icon
  • Icon
  • Icon
    Molecular Biology
  • Icon
  • Icon
    RNA Technology
  • Icon


Various articles in high-ranking scientific journals including “Nature“, „Science“, „Cell“, „EMBO Journal“, „Molecular Cell“, „Nature Structural & Molecular Biology“, „RNA“, „Journal of Biological Chemistry“.

Speaking Engagements

München 2019

„Overview on Recent Developments in Japanese Patent Practice“, „Start. Smart.Global – Japan Workshop“, BioM Biotech Cluster Development GmbH

Munich 2018

“Patent Protection in Japan. Latest Initiatives”, “Start. Smart. Japan”, BioM Biotech Cluster Development GmbH

Munich 2017

“Patentschutz in Japan. Patentierungsmöglichkeiten, Durchsetzung und Widerruf japanischer Patente”, InnoMuNiCH 1st Round Table Japan, BioM Biotech Cluster Development GmbH

Munich 2016

“Patent Protection in Precision Medicine – Genes, Risk Scores and the Importance of Second Medical Use Claims”, 6th Munich Biomarker Conference

Heidelberg 2016

“Produktschutz durch Marken und Designs. Rechtliche Voraussetzungen und praktische Anwendungen”, BioRN Network Heidelberg

Cologne, 2016

“Patent Protection for Diagnostics and Therapeutics – the Essentials and Importance of Second Medical Use Claims in Precision Medicine”, 10th Global Annual Oncologists Meeting